Two Sigma Securities, LLC Guardant Health, Inc. Call Options Transaction History

Two Sigma Securities, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$25.8 - $39.97 $384,420 - $595,553	14,900 Added 173.26%	23,500 $696,000
Q2 2023 Aug 14, 2023	SELL	$20.94 - $38.01 $18,846 - $34,209	-900 Reduced 9.47%	8,600 $307,000
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $217,740 - $320,720	9,500 New	9,500 $222,000
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $256,498 - $688,415	8,900 Added 370.83%	11,300 $456,000
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $59,262 - $79,301	600 Added 33.33%	2,400 $300,000
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $197,586 - $298,224	1,800 New	1,800 $224,000
Q4 2020 Feb 16, 2021	SELL	$99.96 - $135.93 $239,903 - $326,232	-2,400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$80.32 - $111.8 $192,767 - $268,320	2,400 New	2,400 $268,000
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $714,384 - $1.07 Million	-12,100 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $719,829 - $1 Million	12,100 New	12,100 $945,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.